Come up with a name for your new list and we'll add to it:
ViaCyte raised a round of funding on September 25, 2018. Investors include
W. L. Gore & Associates.
ViaCyte, a private company that has emerged as a provider in the field of regenerative medicine, is focused on developing a therapy for the treatment of diabetes. The Company's lead product is based o…